Location History:
- Kineton Warwickshire, GB (2003)
- Nottingham, GB (2018 - 2022)
Company Filing History:
4 out of 8 Years Active: 2003-2022
Title: The Innovative Mind of Richard James Brown
Introduction
Richard James Brown, an accomplished inventor based in Nottingham, GB, has made significant contributions in the field of pharmaceutical compounds with a focus on cancer treatment. Holding a total of four patents, Brown's work reflects his dedication to advancing medical science and improving treatment options for patients battling cancer, particularly prostate cancer.
Latest Patents
Brown's latest innovations include two patents for a compound that falls under the classification of arylimidazolyl isoxazole, represented as formula (I). This compound or its pharmaceutically acceptable salt has been identified for its efficacy in modulating the activity of p300 and/or CBP, making it a promising candidate in the fight against prostate cancer. These patents highlight his commitment to exploring and developing effective therapeutic strategies that target cancer at the molecular level.
Career Highlights
Richard James Brown is currently associated with Cellcentric Limited, a company renowned for its work in the development of next-generation cancer therapies. His role at Cellcentric Limited positions him at the forefront of innovative research aimed at creating more effective treatment solutions for cancer patients.
Collaborations
Throughout his career, Brown has collaborated with notable coworkers such as Neil Anthony Pegg and David Michel Adrien Taddei. These partnerships enhance the research environment and foster collective innovation, allowing for the pooling of ideas and expertise, further driving advancements in pharmaceutical science.
Conclusion
Richard James Brown's contributions to the field of pharmaceuticals underscore the importance of innovation in healthcare. With a focus on developing compounds that target serious conditions like cancer, his work not only advances scientific knowledge but also provides hope for better treatment options. As he continues his research at Cellcentric Limited, the impact of his inventions is poised to make a lasting difference in the lives of those affected by cancer.